| ACLY High (N=267) |
ACLY Low (N=268) |
P-value | |
|---|---|---|---|
| sex | |||
| FEMALE | 109 (40.8%) | 77 (28.7%) | 0.00443 |
| MALE | 158 (59.2%) | 191 (71.3%) | |
| age | |||
| older | 133 (49.8%) | 135 (50.4%) | 0.966 |
| younger | 134 (50.2%) | 133 (49.6%) | |
| stage | |||
| I/II | 180 (67.4%) | 149 (55.6%) | 0.00653 |
| III/IV | 87 (32.6%) | 119 (44.4%) | |
| grade | |||
| G1 | 10 (3.7%) | 4 (1.5%) | 0.00546 |
| G2 | 129 (48.3%) | 102 (38.1%) | |
| G3 | 100 (37.5%) | 109 (40.7%) | |
| G4 | 27 (10.1%) | 48 (17.9%) | |
| GX | 1 (0.4%) | 5 (1.9%) | |
| T | |||
| T1/2 | 184 (68.9%) | 161 (60.1%) | 0.0408 |
| T3/4 | 83 (31.1%) | 107 (39.9%) | |
| N | |||
| N0 | 123 (46.1%) | 117 (43.7%) | 0.554 |
| N1 | 6 (2.2%) | 10 (3.7%) | |
| NX | 138 (51.7%) | 141 (52.6%) | |
| M | |||
| M0 | 221 (82.8%) | 203 (75.7%) | 0.0268 |
| M1 | 28 (10.5%) | 50 (18.7%) | |
| MX | 18 (6.7%) | 15 (5.6%) | |
| pharmaceutical | |||
| NO | 243 (91.0%) | 217 (81.0%) | 0.00128 |
| YES | 24 (9.0%) | 51 (19.0%) | |
| smoking | |||
| less | 141 (52.8%) | 160 (59.7%) | 0.129 |
| more | 126 (47.2%) | 108 (40.3%) | |
| Event | |||
| 0 | 205 (76.8%) | 157 (58.6%) | <0.001 |
| 1 | 62 (23.2%) | 111 (41.4%) |